- Home
- EVGOW vs SIGA Comparison
EVGOW vs SIGA Comparison
Compare EVGOW & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGOW
- SIGA
- Stock Information
- Founded
- EVGOW 2010
- SIGA 1995
- Country
- EVGOW United States
- SIGA United States
- Employees
- EVGOW 331
- SIGA N/A
- Industry
- EVGOW Other Specialty Stores
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- EVGOW Consumer Discretionary
- SIGA Health Care
- Exchange
- EVGOW Nasdaq
- SIGA Nasdaq
- Market Cap
- EVGOW N/A
- SIGA 515.1M
- IPO Year
- EVGOW N/A
- SIGA 1997
- Fundamental
- Price
- EVGOW $0.18
- SIGA $9.00
- Analyst Decision
- EVGOW
- SIGA
- Analyst Count
- EVGOW 0
- SIGA 0
- Target Price
- EVGOW N/A
- SIGA N/A
- AVG Volume (30 Days)
- EVGOW 74.7K
- SIGA 513.2K
- Earning Date
- EVGOW 03-07-2025
- SIGA 11-06-2025
- Dividend Yield
- EVGOW N/A
- SIGA 6.67%
- EPS Growth
- EVGOW N/A
- SIGA N/A
- EPS
- EVGOW N/A
- SIGA 1.14
- Revenue
- EVGOW $239,306,000.00
- SIGA $179,639,422.00
- Revenue This Year
- EVGOW N/A
- SIGA N/A
- Revenue Next Year
- EVGOW N/A
- SIGA $115.06
- P/E Ratio
- EVGOW N/A
- SIGA $7.89
- Revenue Growth
- EVGOW 73.08
- SIGA 3.86
- 52 Week Low
- EVGOW $0.12
- SIGA $4.95
- 52 Week High
- EVGOW $1.99
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- EVGOW 52.31
- SIGA 61.23
- Support Level
- EVGOW N/A
- SIGA $8.49
- Resistance Level
- EVGOW $0.17
- SIGA $9.16
- Average True Range (ATR)
- EVGOW 0.01
- SIGA 0.29
- MACD
- EVGOW -0.00
- SIGA -0.01
- Stochastic Oscillator
- EVGOW 97.30
- SIGA 83.51
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.